Q1 2022 13F Holders as of 3/31/2022
-
Type / Class
-
Equity / Class B Common Stock
-
Shares outstanding
-
5.07M
-
Number of holders
-
494
-
Total 13F shares, excl. options
-
19.1M
-
Shares change
-
+65.9K
-
Total reported value, excl. options
-
$10.7B
-
Value change
-
-$18.7M
-
Put/Call ratio
-
1.46
-
Number of buys
-
239
-
Number of sells
-
-257
-
Price
-
$563.23
Significant Holders of BIO-RAD LABORATORIES, INC. - Class B Common Stock (BIO) as of Q1 2022
591 filings reported holding BIO - BIO-RAD LABORATORIES, INC. - Class B Common Stock as of Q1 2022.
BIO-RAD LABORATORIES, INC. - Class B Common Stock (BIO) has 494 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 19.1M shares
.
Largest 10 shareholders include VANGUARD GROUP INC (2.32M shares), BlackRock Inc. (1.76M shares), STATE STREET CORP (985K shares), FMR LLC (930K shares), ALLIANCEBERNSTEIN L.P. (653K shares), BROWN ADVISORY INC (582K shares), MARSHALL WACE, LLP (467K shares), GEODE CAPITAL MANAGEMENT, LLC (439K shares), ACADIAN ASSET MANAGEMENT LLC (416K shares), and BANK OF AMERICA CORP /DE/ (394K shares).
This table shows the top 494 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.